Home › Funds › Logos Global Management LP › XENE

Logos Global Management LP position in XENE

XENON PHARMACEUTICALS INC · Health Care

Logos Global Management LP reported holding 450,000 shares of XENE (XENON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$27.2M, representing 1.17% of its reported portfolio and ranking #28 among its reported holdings. Logos Global Management LP has disclosed XENE holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)450.00K sh
Reported value held$27.16M
Portfolio Weight1.17%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Logos Global Management LP's XENE position evolved

Logos Global Management LP first disclosed a stake in XENE in Q3 2023 at 450,000 shares (US$15.4M). The position peaked in Q2 2026 at 450,000 shares, worth US$27.2M. Across 6 filings, Logos Global Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 450,000 shares valued at US$27.2M. Notable position changes include a 67% trim in Q4 2023 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 450.00K $15.37M New
Q4 2023 150.00K $6.91M Reduce
Q2 2024 375.00K $14.62M New
Q1 2025 650.00K $21.81M New
Q1 2026 450.00K $26.17M New
Q2 2026 450.00K $27.16M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XENE and 13F data

XENE (XENON PHARMACEUTICALS INC) is a Health Care company. 44 other funds we track also report a position in XENE — the largest reported positions include Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XENE

All XENE fund holders →

FAQ

How long has Logos Global Management LP held XENE?

Logos Global Management LP has disclosed XENE holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is Logos Global Management LP's current position in XENE?

As of Q2 2026, Logos Global Management LP holds 450.00K shares of XENE (XENON PHARMACEUTICALS INC), valued at $27.16M, representing 1.17% of its reported portfolio and ranking #28.

Has Logos Global Management LP been buying or selling XENE?

In the latest 13F filing (Q2 2026), Logos Global Management LP held unchanged its position in XENE. The position peaked in Q2 2026 at 450.00K shares.

Which other funds hold XENE?

Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.